What is LOPJLB’s current signal on PGEN?

LOPJLB’s latest quantitative signal on Precigen, Inc. (PGEN) is SELL in a BEAR regime. Signals are updated daily.

What market regime is PGEN in?

Precigen, Inc. (PGEN) is currently classified in the BEAR HMM market regime on LOPJLB.

What does Precigen, Inc. (PGEN) do?

Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies. Its extensive portfolio of proprietary platforms includes UltraVector, which leverages advanced DNA c…

Precigen, Inc. (PGEN)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$7.36-1.60%Close

SELLBEAR · day 1

Company news

defenseworld.net · 5d ago

Pyxis Oncology (NASDAQ:PYXS) & Precigen (NASDAQ:PGEN) Head to Head Analysis

zacks.com · 10d ago

PGEN Stock Up More Than 50% in 3 Months: Here's What You Should Know

defenseworld.net · 10d ago

Comparing PTC Therapeutics (NASDAQ:PTCT) and Precigen (NASDAQ:PGEN)

zacks.com · 13d ago

4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike

zacks.com · 14d ago

Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock?

zacks.com · 15d ago

PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential?

seekingalpha.com · 15d ago

Precigen: The FDA's Platform Technology Designation And The Institutional Crossover Effect

zacks.com · 21d ago

Can PGEN's AdenoVerse Pipeline Create Growth Beyond Papzimeos?

defenseworld.net · 22d ago

Precigen (NASDAQ:PGEN) Hits New 1-Year High – Time to Buy?

prnewswire.com · 24d ago

Precigen Receives FDA Platform Technology Designation for AdenoVerse Platform

defenseworld.net · 28d ago

Head-To-Head Comparison: Precigen (NASDAQ:PGEN) and Celldex Therapeutics (NASDAQ:CLDX)

zacks.com · 31d ago

Precigen Gains 43% in 3 Months: Is It an Indication to Buy the Stock?

zacks.com · 35d ago

Can Papzimeos Drive Precigen's Growth Through the Rest of 2026?

defenseworld.net · 37d ago

Legal & General Group Plc Takes $730,000 Position in Precigen, Inc. $PGEN

zacks.com · 49d ago

Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen

zacks.com · 50d ago

5 Biotech Stocks Worth Adding to Your Portfolio Now

accessnewswire.com · 51d ago

Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers

zacks.com · 56d ago

Reasons Why Investors Should Consider Betting on PGEN Stock

zacks.com · 62d ago

Are You Looking for a Top Momentum Pick? Why Precigen, Inc. (PGEN) is a Great Choice

seekingalpha.com · 69d ago

Precigen: Has To Grow Into Its Valuation

Market news & ticker search · RSS for PGEN

FAQ

What is LOPJLB’s current signal on PGEN?: LOPJLB’s latest quantitative signal on Precigen, Inc. (PGEN) is SELL in a BEAR regime. Signals are updated daily.
What market regime is PGEN in?: Precigen, Inc. (PGEN) is currently classified in the BEAR HMM market regime on LOPJLB.
What does Precigen, Inc. (PGEN) do?: Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies. Its extensive portfolio of proprietary platforms includes UltraVector, which leverages advanced DNA c…

Precigen, Inc. (PGEN)

Key stats

Industry peers

Prediction markets

Company news

FAQ